Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ZIMMER BIOMET HOLDINGS, INC. : Ex-dividend day for

09/29/2020 EDT

A dividend is removed today from Zimmer Biomet Holdings, Inc.'s share.



ę Factset 2020
All news about ZIMMER BIOMET HOLDINGS, INC.
06/15BACTIGUARDá : coated Zimmer Biomet trauma implants for infection prevention laun..
AQ
06/07Zimmer Biomet Holdings Names Chief Science, Technology and Innovation Officer
MT
05/25ZIMMER BIOMETá : Barclays Starts Zimmer Biomet Holdings at Overweight With $210 ..
MT
05/20ZIMMER BIOMET HOLDINGS, INC.á : Change in Directors or Principal Officers, Amend..
AQ
05/19ZIMMER BIOMETá : to Present at Bernstein's 37th Annual Strategic Decisions Confe..
PR
05/11ZIMMER BIOMETá : JMP Securities Adjusts Price Target on Zimmer Biomet Holdings t..
MT
05/05ZIMMER BIOMETá : Oppenheimer Adjusts Zimmer Biomet Holdings PT to $195 From $185..
MT
05/05ZIMMER BIOMETá : UBS Adjusts Price Target on Zimmer Biomet Holdings to $195 From..
MT
05/05ZIMMER BIOMETá : Morgan Stanley Adjusts Price Target for Zimmer Biomet to $195 F..
MT
05/05ZIMMER BIOMETá : JPMorgan Adjusts Price Target for Zimmer Biomet Holdings to $17..
MT
More news
Financials (USD)
Sales 2021 8 125 M - -
Net income 2021 1 063 M - -
Net Debt 2021 6 215 M - -
P/E ratio 2021 31,2x
Yield 2021 0,61%
Capitalization 32 946 M 32 946 M -
EV / Sales 2021 4,82x
EV / Sales 2022 4,41x
Nbr of Employees 20 000
Free-Float 66,7%
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 31
Average target price 190,82 $
Last Close Price 158,03 $
Spread / Highest target 32,9%
Spread / Average Target 20,8%
Spread / Lowest Target -15,2%
EPS Revisions
Managers and Directors
NameTitle
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS, INC.2.56%32 946
ABBOTT LABORATORIES0.52%195 557
MEDTRONIC PLC6.73%168 202
BECTON, DICKINSON AND COMPANY-3.97%69 878
HOYA CORPORATION0.11%48 576
ALIGN TECHNOLOGY, INC.12.20%47 450